[Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy.]

Ardashev, Andrey, Oseroff, Oscar, Sansalone, Rodolfo, Zhelyakov, Evgeny G., Cappato, Riccardo, Snezhitskiy, Viktor, Kanorskii, Sergey, Abzalieva, Symbat, Belenkov, Yury, Karpenko, Yury, Puodziukynas, Aras, Sayganov, Sergey A., Santini, Luca, Speranza, Ricardo, Yakovleva, Marina, Kolotsey, Ludmila

Ardashev, Andrey, Oseroff, Oscar, Sansalone, Rodolfo, Zhelyakov, Evgeny G., Cappato, Riccardo, Snezhitskiy, Viktor, Kanorskii, Sergey, Abzalieva, Symbat, Belenkov, Yury, Karpenko, Yury, Puodziukynas, Aras, Sayganov, Sergey A., Santini, Luca, Speranza, Ricardo, Yakovleva, Marina, Kolotsey, Ludmila.

Kardiologiia ; 60(10):4-12, 2020.

Article in Russian | ProQuest Central | ID: covidwho-1870588

ABSTRACT

ABSTRACT

Recommendation provides information to employees of medical departments at any level and primarily primary care about the possible proarrhythmic and adverse effects of drugs used for the treatment of COVID-19 patients and the features of therapy for COVID-19 patients with heart rhythm and conduction disorders receiving permanent antiarrhythmic therapy.

Keywords

Anti-Arrhythmia Agents; 0; Index Medicus; COVID-19; SARS-CoV-2; Arrhythmias, Cardiac -- chemically induced; Humans; Betacoronavirus; Arrhythmias, Cardiac -- therapy; Pandemics; Pneumonia, Viral; Anti-Arrhythmia Agents -- adverse effects; Coronavirus Infections -- drug therapy

Search on Google

XML

Collection: Databases of international organizations Database: ProQuest Central Type of study: Experimental Studies Language: Russian Journal: Kardiologiia Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML